Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Untreated Chronic Lymphocytic Leukemia”

297 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 297 results

Testing effectiveness (Phase 2)Study completedNCT00410163
What this trial is testing

Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients

Who this might be right for
Leukaemia, Lymphocytic, Chronic
GlaxoSmithKline 61
Testing effectiveness (Phase 2)Study completedNCT00057811
What this trial is testing

Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Diffuse Large Cell LymphomaChildhood Immunoblastic Large Cell Lymphoma+9 more
Children's Oncology Group 97
Large-scale testing (Phase 3)Active Not RecruitingNCT03336333
What this trial is testing

A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
BeiGene 590
Testing effectiveness (Phase 2)Study completedNCT01563055
What this trial is testing

A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukaemia, Lymphocytic, Chronic
GlaxoSmithKline 10
Testing effectiveness (Phase 2)Study completedNCT00003248
What this trial is testing

Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Alliance for Clinical Trials in Oncology 104
Testing effectiveness (Phase 2)Looking for participantsNCT06849713
What this trial is testing

Zanubrutinib, Obinutuzumab, and Sonrotoclax in Previously Untreated Patients With CLL or SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma (SLL)
Massachusetts General Hospital 40
Early research (Phase 1)Study completedNCT00042900
What this trial is testing

Pyroxamide in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT06073821
What this trial is testing

Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
CLL
BeOne Medicines 652
Testing effectiveness (Phase 2)Ended earlyNCT00771056
What this trial is testing

Hydroxychloroquine in Untreated B-CLL Patients

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Northwell Health 23
Testing effectiveness (Phase 2)Study completedNCT00049075
What this trial is testing

Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
NCIC Clinical Trials Group 128
Testing effectiveness (Phase 2)Study completedNCT01868893
What this trial is testing

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Genentech, Inc. 20
Not applicableStudy completedNCT03374137
What this trial is testing

Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaFollicular Lymphoma
Hoffmann-La Roche 55
Testing effectiveness (Phase 2)Study completedNCT00532129
What this trial is testing

MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia.

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 100
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00018954
What this trial is testing

Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
National Institutes of Health Clinical Center (CC)
Post-approval studies (Phase 4)UnknownNCT00131313
What this trial is testing

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Who this might be right for
Chronic Lymphocytic Leukemia
East Valley Hematology and Oncology Medical Group 180
Testing effectiveness (Phase 2)Study completedNCT00784927
What this trial is testing

Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Mayo Clinic 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT04963946
What this trial is testing

STop and Restart Acalabrutinib In fRail Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Untreated Chronic Lymphocytic Leukemia
French Innovative Leukemia Organisation 160
Testing effectiveness (Phase 2)Study completedNCT00280241
What this trial is testing

Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
University of Pittsburgh 65
Large-scale testing (Phase 3)Active Not RecruitingNCT01886872
What this trial is testing

Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Stage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+1 more
National Cancer Institute (NCI) 547
Load More Results